Tech Company Financing Transactions
NeuroPace Funding Round
NeuroPace, operating out of Mountain View, secured $67 million from Accelmed, KCK Group and OrbiMed.
Transaction Overview
Company Name
Announced On
9/2/2020
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$67,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds will be used to accelerate commercial growth and to pursue expanded indications for the RNS System.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
455 N. Bernardo Ave.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Favet
Chief Financial Officer
Rebecca Kuhn
Chief Medical Officer
Martha Morrell
VP - General Counsel
Pamela Maher
VP - Human Resources
Irene Thomas
VP - Marketing
Chi Nguyen
VP - Regulatory Affairs
Isabella Abati
VP - Sales
Mark Saxton
Browse more venture capital transactions:
Prev: 9/2/2020: Patreon venture capital transaction
Next: 9/2/2020: Cloud Agronomics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs